vs
Cytek Biosciences, Inc.（CTKB）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC BANCORP INC的季度营收约是Cytek Biosciences, Inc.的1.5倍（$94.3M vs $62.1M），REPUBLIC BANCORP INC净利率更高（24.2% vs -70.9%，领先95.1%），Cytek Biosciences, Inc.同比增速更快（8.1% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs -11.5%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
CTKB vs RBCAA — 直观对比
营收规模更大
RBCAA
是对方的1.5倍
$62.1M
营收增速更快
CTKB
高出2.8%
5.3%
净利率更高
RBCAA
高出95.1%
-70.9%
自由现金流更多
RBCAA
多$162.9M
$-1.8M
两年增速更快
CTKB
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $94.3M |
| 净利润 | $-44.1M | $22.8M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 29.3% |
| 净利率 | -70.9% | 24.2% |
| 营收同比 | 8.1% | 5.3% |
| 净利润同比 | -557.1% | 20.0% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBRBCAA
| Q4 25 | $62.1M | $94.3M | ||
| Q3 25 | $52.3M | $93.5M | ||
| Q2 25 | $45.6M | $93.8M | ||
| Q1 25 | $41.5M | $135.8M | ||
| Q4 24 | $57.5M | $89.5M | ||
| Q3 24 | $51.5M | $88.1M | ||
| Q2 24 | $46.6M | $86.9M | ||
| Q1 24 | $44.9M | $120.3M |
净利润CTKBRBCAA
| Q4 25 | $-44.1M | $22.8M | ||
| Q3 25 | $-5.5M | $29.7M | ||
| Q2 25 | $-5.6M | $31.5M | ||
| Q1 25 | $-11.4M | $47.3M | ||
| Q4 24 | $9.6M | $19.0M | ||
| Q3 24 | $941.0K | $26.5M | ||
| Q2 24 | $-10.4M | $25.2M | ||
| Q1 24 | $-6.2M | $30.6M |
毛利率CTKBRBCAA
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBRBCAA
| Q4 25 | -9.0% | 29.3% | ||
| Q3 25 | -17.6% | 40.4% | ||
| Q2 25 | -23.3% | 43.0% | ||
| Q1 25 | -36.1% | 44.1% | ||
| Q4 24 | 5.2% | 25.8% | ||
| Q3 24 | -8.2% | 38.4% | ||
| Q2 24 | -18.3% | 37.0% | ||
| Q1 24 | -23.9% | 32.2% |
净利率CTKBRBCAA
| Q4 25 | -70.9% | 24.2% | ||
| Q3 25 | -10.5% | 31.8% | ||
| Q2 25 | -12.2% | 33.5% | ||
| Q1 25 | -27.5% | 34.8% | ||
| Q4 24 | 16.8% | 21.2% | ||
| Q3 24 | 1.8% | 30.1% | ||
| Q2 24 | -22.4% | 29.0% | ||
| Q1 24 | -13.8% | 25.4% |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $1.1B |
| 总资产 | $461.5M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBRBCAA
| Q4 25 | $90.9M | $220.0M | ||
| Q3 25 | $93.3M | $484.2M | ||
| Q2 25 | $75.5M | $484.8M | ||
| Q1 25 | $95.3M | $793.0M | ||
| Q4 24 | $98.7M | $432.2M | ||
| Q3 24 | $162.3M | $530.9M | ||
| Q2 24 | $177.9M | $400.1M | ||
| Q1 24 | $168.8M | $546.4M |
股东权益CTKBRBCAA
| Q4 25 | $341.7M | $1.1B | ||
| Q3 25 | $378.6M | $1.1B | ||
| Q2 25 | $377.6M | $1.1B | ||
| Q1 25 | $379.6M | $1.0B | ||
| Q4 24 | $395.7M | $992.0M | ||
| Q3 24 | $385.5M | $979.7M | ||
| Q2 24 | $389.1M | $955.4M | ||
| Q1 24 | $392.6M | $935.6M |
总资产CTKBRBCAA
| Q4 25 | $461.5M | $7.0B | ||
| Q3 25 | $494.9M | $7.0B | ||
| Q2 25 | $493.3M | $7.0B | ||
| Q1 25 | $482.6M | $7.1B | ||
| Q4 24 | $499.5M | $6.8B | ||
| Q3 24 | $491.2M | $6.7B | ||
| Q2 24 | $483.7M | $6.6B | ||
| Q1 24 | $492.1M | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $161.1M |
| 自由现金流率自由现金流/营收 | -2.9% | 170.9% |
| 资本支出强度资本支出/营收 | 1.6% | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $288.6M |
8季度趋势，按日历期对齐
经营现金流CTKBRBCAA
| Q4 25 | $-771.0K | $168.2M | ||
| Q3 25 | $-3.9M | $33.3M | ||
| Q2 25 | $108.0K | $8.4M | ||
| Q1 25 | $-125.0K | $93.2M | ||
| Q4 24 | $2.0M | $149.0M | ||
| Q3 24 | $13.2M | $51.3M | ||
| Q2 24 | $6.2M | $4.0M | ||
| Q1 24 | $4.0M | $71.2M |
自由现金流CTKBRBCAA
| Q4 25 | $-1.8M | $161.1M | ||
| Q3 25 | $-4.6M | $30.8M | ||
| Q2 25 | $-1.5M | $5.2M | ||
| Q1 25 | $-974.0K | $91.6M | ||
| Q4 24 | $1.1M | $143.2M | ||
| Q3 24 | $12.2M | $49.8M | ||
| Q2 24 | $5.2M | $2.7M | ||
| Q1 24 | $3.4M | $69.1M |
自由现金流率CTKBRBCAA
| Q4 25 | -2.9% | 170.9% | ||
| Q3 25 | -8.7% | 32.9% | ||
| Q2 25 | -3.2% | 5.5% | ||
| Q1 25 | -2.3% | 67.4% | ||
| Q4 24 | 1.9% | 160.0% | ||
| Q3 24 | 23.7% | 56.5% | ||
| Q2 24 | 11.0% | 3.1% | ||
| Q1 24 | 7.6% | 57.5% |
资本支出强度CTKBRBCAA
| Q4 25 | 1.6% | 7.5% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 3.5% | 3.5% | ||
| Q1 25 | 2.0% | 1.2% | ||
| Q4 24 | 1.6% | 6.5% | ||
| Q3 24 | 2.0% | 1.7% | ||
| Q2 24 | 2.3% | 1.5% | ||
| Q1 24 | 1.3% | 1.7% |
现金转化率CTKBRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | 0.21× | 7.84× | ||
| Q3 24 | 14.05× | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
RBCAA
暂无分部数据
